SRRA - Sierra Oncology, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
43,024
41,078
30,157
33,895
Selling General and Administrative
13,598
14,339
12,462
14,180
Total Operating Expenses
56,622
55,417
42,619
48,075
Operating Income or Loss
-56,622
-55,417
-42,619
-48,075
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
1,408
1,780
760
351
Income Before Tax
-55,214
-53,637
-41,859
-47,724
Income Tax Expense
-118
-302
156
143
Income from Continuing Operations
-55,096
-53,335
-42,015
-47,867
Net Income
-55,096
-53,335
-42,015
-47,867
Net Income available to common shareholders
-55,096
-53,335
-42,015
-47,867
Reported EPS
Basic
-
-30.00
-33.60
-63.20
Diluted
-
-30.00
-33.60
-63.20
Weighted average shares outstanding
Basic
-
1,768
1,247
756
Diluted
-
1,768
1,247
756
EBITDA
-
-55,306
-42,361
-47,878